Mesoblast dives after deal axed
Novartis has terminated a respiratory distress syndrome cell therapy deal with listed regenerative medicine company Mesoblast.
Novartis has terminated a respiratory distress syndrome cell therapy deal with listed regenerative medicine company Mesoblast.
Australia is running out of rental properties with vacancy rates falling to unprecedented lows across much of the country, with one city having just 97 properties available to rent.
ASX closes flat on real estate gains and heavy retail losses, CSL to buy Vifor for $16.4bn, Mesoblast tumbles 17.4 per cent, Woolies dives on profit warning and Polynovo soars 15.4 per cent.
ASX closes higher on property and energy gains, Wyloo Metals trumps BHP offer for Noront, Charter Hall surges on guidance and ANZ arm extends Cashrewards takeover.
Crown Resorts chief executive Steve McCann will on Monday hold the gaming group’s first investor day since it received an $8.5bn takeover offer from Blackstone in November.
The ACCC is taking Australia’s largest online book retailer to court over allegedly false or misleading claims about its refund policy.
ASX closes down 0.42 per cent with health and energy weak, Santos-Oil Search merger complete, and HomeCo restructure wins investor approval.
ACCC will not oppose the $23.6bn acquisition of Australia’s biggest airport, finding that it already has a “natural monopoly”.
ASX closed down 0.28% with tech stocks weak, PNG courts approve Santos-Oil Search deal, Woodside targets east coast, Sydney Airport lifts on ACCC backing and jobs recovery slows.
The market’s strong run continues, closing up 1.25 per cent, led by tech and mining stocks. Woodside to invest $7bn in new energy, and telcos fork out $2bn on 5G spectrum.
Original URL: https://www.theaustralian.com.au/author/matt-bell/page/110